Results 11 to 20 of about 383,605 (247)
Hepatocellular carcinoma [PDF]
Nature Reviews Disease Primers, 2016 Liver cancer is the second leading cause of cancer-related deaths globally and has an incidence of approximately 850,000 new cases per year. Hepatocellular carcinoma (HCC) represents approximately 90% of all cases of primary liver cancer. The main risk factors for developing HCC are well known and include hepatitis B and C virus infection, alcohol ...
Llovet, Josep M. +6 more
+9 more sources
Hepatocellular carcinoma [PDF]
Journal of British Surgery, 1998 Abstract Background Hepatocellular carcinoma is one of the world's most common malignancies. The aims of the present paper are to review data on (1) epidemiology and screening programmes for the early detection of the tumour and (2) advances in the diagnostic imaging and management.
Akriviadis, E. A. +6 more
+8 more sources
Hepatocellular carcinoma [PDF]
British Journal of Cancer, 2001 The number of papers published regarding hepatocellular carcinoma between 1999 and 2001 increased from previous years. This year a study confirmed the increase in incidence in the United States. Also, several studies established for the first time that tobacco smoking was a risk factor for the development of this tumor. Several studies established that
Giovannini, M +4 more
+7 more sources
Hepatocellular Carcinoma [PDF]
Cold Spring Harbor Perspectives in Medicine, 2015 The hepatitis B virus (HBV) is a widespread human pathogen that causes liver inflammation, cirrhosis, and hepatocellular carcinoma (HCC). Recent sequencing technologies have refined our knowledge of the genomic landscape and pathogenesis of HCC, but the mechanisms by which HBV exerts its oncogenic role remain controversial.
Marie-Annick, Buendia +1 more
openaire +2 more sources
Gut and Liver, 2020 Background/Aims: The Response Evaluation Criteria in Solid Tumors (RECIST) 1.1 and modified RECIST (mRECIST) criteria have been used to assess treatment responses for hepatocellular carcinoma (HCC) patients. We investigated which criteria provides better
Jae Seung Lee +12 more
doaj +1 more source
Molecular Oncology, 2019 The cross‐talk between hepatic stellate cells (HSCs) and hepatic carcinoma cells contributes to hepatocellular carcinoma (HCC) progression, but the underlying mechanism is largely unknown.
Jie Li +17 more
doaj +1 more source
Gut and Liver, 2020 In 2007, the first associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) procedure was performed in Regensburg, Germany. ALPPS is a variation of twostage hepatectomy to induce rapid liver hypertrophy allowing the removal of ...
Hauke Lang +2 more
doaj +1 more source
Gut and Liver, 2020 Background/Aims: von Willebrand factor antigen (vWF-Ag) is a noninvasive predictor of portal hypertension that serves as a negative prognostic marker in various malignancies. Increased portal hypertension is associated with higher postoperative morbidity
Christoph Schwarz +8 more
doaj +1 more source
Clopidogrel‐induced liver damage: A case report and review of the literature
Clinical Case Reports, 2020 Liver damage is a rare side effect of clopidogrel. That is reversible in most cases. Considering the widespread use of this medication in cardiovascular diseases, the management of hepatotoxicity requires further meticulous investigation.
Vahid Eslami, Azin Gheymati
doaj +1 more source
Gut and Liver, 2020 Background/Aims: This study aimed to elucidate the epidemiological and clinical characteristics of chronic hepatitis C (CHC) patients in South Korea from 2007 to 2017 and to compare the treatment patterns between two periods before and after the first ...
Joon Yeul Nam +11 more
doaj +1 more source